Abac solutions and the directive board of PronoKal Group acquire the 100 % shares of the leading Company in medical treatments against overweight and obesity

SOURCE: El Confidencial / El Economista...

Abac solutions and the directive board of PronoKal Group acquire the 100 % shares of the leading Company in medical treatments against overweight and obesity

The venture capital fund Abac solutions (SCA) SICAR (“Abac”) and the directive board of PronoKal Group have jointly purchase the 100 5 of the company to its funders with the aim of supporting its expansion process all around Europe and Latin America.

PronoKal Group is a leading company across the world specializing in medical treatments for obesity and overweight based on a protein diet, it has an annual turnover over 42 million euros and it is present in 15 countries in Europe and Latin America.

Abac’s and the directive board’s investment aims to increase the presence of the group in other European and Latin American countries, in which obesity is a wide spread illness. PronoKal Group, which after its acquisition will continue to be led by its current directive board, will perpetuate the research for developing new treatments and the improvement of the current ones, and it will bolster 9 new launchings in the next 5 years in countries as Germany, the US, Colombia or Chile, with which it foresees to double its annual turnover.

Oriol Pinya, founding partner of Abac Capital, has stated to be “excited with this new venture. We trust to be able to support the directive board to boost the growth of the company through its international expansion as well as keep going towards a greater professionalization”.

On his behalf, Dr. Joan Fondevila, CEO of PronoKal Group and one of the members of the directive board that has become a shareholder, has stated to be “fully convinced that this new stage that we are beginning with Abac will prove vital to boost the company’s growth, as well as to invest in new and better treatments that consolidate our leadership in the industry”.

Read in El Confidencial...

Read in El Economista...

Read in La Vanguardia...

Read in Expansión...

Read in Farmaventas...

Read in VilaWeb...

Read in El Día...

Read in Te Interesa...

Read in Última Hora Press...

Read in LaInformacion.com...

Read in Finanzas...

Read in La Voz Libre...

Latest news See all

- Abac backs PronoKal MBO [04/06/2017 • realdeals.eu.com]

- Abac Solutions acquires PronoKal Group [04/05/2017 • Private Equity Wire]